Fatal Cerebral Infarction After Nasal Augmentation With Hyaluronic Acid

Completed

• Conditions: Magnetic Resonance Angiography

• Registration Number: NCT04189068
• Lead Sponsor: Xijing Hospital

Brief Summary

this study discussed the pathogenesis, treatment, and prognosis of severe cerebral infarction and ophthalmic artery occlusion for Aisan induced by hyalruonic acid filler injection.

Detailed Description

Intra-arterial thrombolysis and retrobulbar injection of hyaluronidase have been used for HA-induced ophthalmic artery obstruction.

Study Timeline

• Study Start: 2019-09-24
• Primary Completion: 2019-10-10
• Study Completion: 2019-10-22
• Study First Submitted: 2019-10-30
• Status Verified: 2019-12
• Study First Submitted QC: 2019-12-05
• Last Update Submitted: 2019-12-05
• Study First Posted: 2019-12-06
• Last Update Posted: 2019-12-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1

Inclusion Criteria

• Clinical diagnosis of cerebral infarction

Exclusion Criteria

• fat embolism

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
blood pressure	0-6 day	Monitor the blood pressure and record with mm Hg over the past 6 days.
pulse	0-6 day	Monitore the "beats per minute over the past 6 days.

Trial Locations

Locations (1)

Qing; 🇨🇳 Xi'an, Shaan XI Province, China